Microtek International

Microtek International ROE

The Return on Equity (ROE) of Microtek International (2305.TW) as of Oct 20, 2026 is 1.74 %. In the previous year, Return on Equity (ROE) was 1.23 % — a change of 40.67% (higher).

ROE

1.74 %

YoY

40.67%

Last updated:

In 2025, Microtek International's return on equity (ROE) was 1.74 %, a 40.67% increase from the 1.23 % ROE in the previous year.

The Microtek International ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2018
-0.89 TWD
Jan 1, 2019
0.28 TWD
Jan 1, 2020
0.77 TWD
Jan 1, 2021
0.92 TWD
Jan 1, 2022
0.86 TWD
Jan 1, 2023
0.31 TWD
Jan 1, 2024
1.23 TWD
Jan 1, 2025
1.74 TWD
The Microtek International ROE history
YEARROEYoY
1.74 %+40.67%
1.23 %+294.74%
0.31 %-63.71%
0.86 %-6.33%
0.92 %+20.06%
0.77 %+176.06%
0.28 %-131.37%
-0.89 %-103.86%
22.91 %+2,389.44%
0.92 %-92.55%
12.34 %+14.20%
10.81 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Microtek International Stock analysis

What does Microtek International do? Microtek International, Inc. generates revenue through its two primary business segments. The Image Scanners segment designs, manufactures, and sells digital imaging devices for commercial, medical, biotechnical, and industrial applications. The Photoelectron Equipment segment focuses on optical passive devices, optical instrumentations, and other photoelectron equipment. The company's products are sold directly to end-users and through its subsidiaries, which also handle medical equipment sales and technology development consultancy. Revenue streams include direct sales of scanners and photoelectron equipment, as well as consultancy services related to medical technology development. The company serves multiple market segments including commercial, medical, biotechnical, and industrial sectors. Its scanners target businesses requiring high-quality image input and output solutions, while photoelectron equipment caters to industries needing optical instrumentation. Medical equipment sales through subsidiaries support healthcare providers and institutions. The Photoelectron Equipment segment's research and manufacturing activities drive sales of optical passive devices and instrumentation, which are key revenue sources. Microtek's product portfolio includes image scanners for various specialized uses and photoelectron equipment such as optical passive devices and optical instrumentations. These products are marketed under the company's own brand without external branding. The Image Scanners segment's commercial, medical, biotechnical, and industrial scanners are sold directly to customers in those respective sectors, while the Photoelectron Equipment segment's offerings are targeted at industries requiring optical solutions. Subsidiaries handle medical equipment sales and technology consultancy, contributing to overall revenue. Microtek International is one of the most popular companies on Eulerpool.

ROE Details

Decoding Microtek International's Return on Equity (ROE)

Microtek International's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Microtek International's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Microtek International's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Microtek International’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Microtek International stock

Return on Equity (ROE) of Microtek International is 1.74 % in 2025.

Return on Equity (ROE) of Microtek International changed from 1.23 % to 1.74 %, representing a 40.67% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Microtek International since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Microtek International with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Microtek International

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Microtek International